ArticleHealth science reports2026
Serum Albumin and Uric Acid Levels Among Hypertensive Patients in Northwest Ethiopia: A Comparative Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Hypertension is a long-term condition marked by consistently high arterial blood pressure. Hypertensive patients often experience altered serum albumin and uric acid, attributed to factors like inflammation, kidney damage, and the activation of the renin angiotensin aldosterone system. However, localized evidence regarding these biomarkers remains scarce within the Ethiopian context. This study aimed to assess the level of serum albumin and uric acid among hypertensive patients. Methods: A comparative cross-sectional study was conducted from March 1 to May 30, 2025, involving 232 study participants selected using systematic random sampling. Of these, 116 were patients with hypertensive and 116 were normotensives. Sociodemographic, behavioral, and clinical data were measured by structured questionnaires. Serum albumin and uric acid levels were measured by spectrophotometric principle. Data were analyzed using SPSS version 25 software. Descriptive statistics, independent Results: The mean age of the study participants was 46 ± 11.4 and 45 ± 11.6 for the case and control groups. There was a statistically significant difference in mean serum albumin and uric acid levels between the case and control groups. The prevalence of hypoalbuminemia and hyperuricemia among hypertensive patients were 25.9% (95% CI: 18.2%, 34.8%) and 23.3% (95% CI: 15.9%, 32%), respectively. Multivariable logistic regression showed hypertensive patients with albuminuria had 3.3 and 16.1 odds of developing hypoalbuminemia and hyperuricemia. Conclusion: This study demonstrates that the prevalence of hypoalbuminemia and hyperuricemia was higher in hypertensive patients than the controls. Albuminuria was a significant predictor of hypoalbuminemia and hyperuricemia. This underscores the potential metabolic alterations that may be associated with hypertension. Thus, it is important to monitor these parameters in hypertensive individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.